Public Domain Human Genome Project Generated More Research And More Commercial Activity Than Proprietary Competitor

from the not-bad dept

Traditionally, there has been a blithe assumption that more innovation occurs when patents are granted than when they are not. But as Techdirt has reported, people are finally beginning to call that into question. A forthcoming paper from an economist at MIT, Heidi Williams, provides another example of where that is not the case: in the field of genomics (via @gsDetermination).

Williams has looked at the academic papers that flowed from two major competing projects: the global Human Genome Project (HGP), which placed all its result in the public domain, and Craig Venter's company Celera, which sought to patent as much as it could of the sequences that it obtained. Here's how National Journal's Brian Fung describes her results:

Using a standard measure of academic-knowledge production, she compared the number of papers published using HGP data and Celera data. By 2009, genes that had been sequenced in 2001 from HGP had produced an average of 2.1 academic papers a year, while genes sequenced that same year by Celera led to just 1.2 papers a year over the next eight years. Even though the annual pace of Celera-linked papers rose rapidly after its IP was lifted in 2003, it never caught up to the rate of publication tied to the always-open non-Celera data.
And if you're worried that this is just one, possibly imperfect measure of innovation, Williams also looked at the number of diagnostic tests developed for both sets of genes. The result was the same: that tests based on the public genome's sequences were twice as common as those based on Celera's patented genes.

She concludes:

If Celera genes had counterfactually had the same rate of subsequent innovation as non-Celera genes, there would have been 1,400 additional publications between 2001 and 2009 and 40 additional diagnostic tests as of 2009
Remarkably, it's not only academically that the Human Genome Project has proved its worth. According to estimates found in a report published in 2011:
between 1988 and 2010, federal investment in genomic research generated an economic impact of $796 billion, which is impressive considering that Human Genome Project (HGP) spending between 1990-2003 amounted to $3.8 billion. This figure equates to a return on investment (ROI) of 141:1 (that is, every $1 invested by the U.S. government generated $141 in economic activity).
(But note that more recent calculations have put the ROI nearer to 60:1 -- lower, but still an impressive figure.)

In other words, as well as growing the store of human knowledge more effectively, publicly-funded research that does not seek patents on its work can provide taxpayers with big economic paybacks, too -- something worth remembering at a time when researchers are under increasing pressure to patent everything they can.

Follow me @glynmoody on Twitter or identi.ca, and on Google+

Filed Under: human genome, public domain


Reader Comments

Subscribe: RSS

View by: Time | Thread


  1. icon
    special-interesting (profile), 24 Apr 2013 @ 4:16am

    A nice report on open sourced genetic research economic benefits with convincing supporting data. In general its a great example of data sharing openness. Good news for a culture based on more sharing of ideas. Compared to the firewall of senseless applications of patent law slowing innovation and new tech. Now if only legislators looked at results and not the campaign contributions from industry special interest groups.

    In this new age where the new areas of research are so broad that they are not covered by patent law its technological suicide for any nation that slows down due to corporate greed. Allowing genes to be patented during a time when we don't even really know what we are talking about is beyond stupid. Its an infant technology where we still don't know what the majority of genes do and especially the long term consequences of modifying them.

    Software patents are similar idiocy. In such an fledgling industry growth is stunted by ridiculous patents issued on simple buttons. (one click to buy) This type of patent abuse should be legislated into oblivion until the technology matures. It will likely take a (conservative) few hundred years to do this if comparing it to mechanical innovation and technology 3000 year development rate. (historically speaking)

    Its becoming a given that if we want to succeed by technological means and innovation there has to be an open data and reduced patent approach. It wont happen any other way. Without the average citizen being included by policy and law into the group of potential innovators we loose a large part of the huge base of intelligence derived from a culture of invention.

    $$$

    The Human Genome Project (HGP) is a model good investment and resulting success. What was so very impressive was the ROI figure of (at least) 60 to 1. We are talking NASA space program comparable returns on investment (ROI) which is what one expects of a good investment of tax dollars.

    The returns from the HGP cannot be valued only in dollars. The value of accurate genetic tests and the exact identify diseases through DNA testing have begun a revolution of medical technology that no superlative can express it.

    To even surpass the above superlatives DNA based treatments to exactly target the previously exactly identified disease is even more astoundingly amazing. Now consider the insanity of slowing such research down with patent prohibitions.


    The argument that open sourced research provides a better ROI than a proprietary method is compelling. However its likely that the officially published figures are skewed in the classic way corporations overestimate their benefits and the oppositely classic way open sourced projects underestimate their contributions.

    Since Celera is a private concern its natural to challenge the ROI figures for the obvious reasons that pressure to show results often produce misleading numbers. They should consider themselves lucky that they aren't viewed to be as bad as the MPAA or RIAA or any associations using Hollywood accounting principles.

    On the other hand (this is not a compliment) considering what firms like Celera spend on special interest lobbying its amazing that they show a profit at all. Any profit is more likely due to the fact that DNA research is so important rather than some proprietary attitude.

    Most open sourced estimates are low and consecutive in comparison. If only because a lot of it is off the records and not officially reported as a category in general accounting methods.

    Its even likely that firms using Celera data also benefited highly from the open sourced community. For reasons of corporate pride they will not likely admit that any investment (in Celera data) would prove a mistake and would most probably under report such gain.

    In short. If a nation wants to hobble its culture of innovation through new technology... chain it to a patent system. It wont go anywhere. At least until the patent expires!

    (Note; This compares directly to the loss of culture from eternal copyright also.)

Add Your Comment

Have a Techdirt Account? Sign in now. Want one? Register here



Subscribe to the Techdirt Daily newsletter




Comment Options:

  • Use markdown. Use plain text.
  • Remember name/email/url (set a cookie)

Follow Techdirt
Techdirt Gear
Show Now: Takedown
Advertisement
Report this ad  |  Hide Techdirt ads
Essential Reading
Techdirt Deals
Report this ad  |  Hide Techdirt ads
Techdirt Insider Chat
Advertisement
Report this ad  |  Hide Techdirt ads
Recent Stories
Advertisement
Report this ad  |  Hide Techdirt ads

Close

Email This

This feature is only available to registered users. Register or sign in to use it.